Katalin "Kati" Karikó (born 17 January 1955) is a Hungarian and American biochemist who specializes in ribonucleic acid (RNA)-mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy. Karikó laid the scientific groundwork for mRNA vaccines, overcoming major obstacles and skepticism in the scientific community. Karikó received the Nobel Prize in Physiology or Medicine in 2023 for her work, along with American immunologist Drew Weissman. Karikó co-founded and was CEO of RNARx from 2006 to 2013. From 2013 to 2022, she was associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. In 2022, she left BioNTech to devote more time to research. In 2021, she received an honorary doctorate from the University of Szeged in Hungary, where she has since become a professor. While Karikó has also been associated with the University of Pennsylvania, which would benefit financially from her eventual discovery, the university had actively discouraged her from pursuing research by underfunding and deprioritizing work on mRNA. After being demoted by the University of Pennsylvania in 1995, Karikó was never granted tenure and joined BioNTech in 2013 after the university had declined to reinstate her. Karikó's work includes scientific research on RNA-mediated immune activation, resulting in the co-discovery with Drew Weissman of the nucleoside modifications that suppress the immunogenicity of RNA. This is seen as a further contribution to the therapeutic use of mRNA. Together with Weissman, she holds United States patents for the application of non-immunogenic, nucleoside-modified RNA. This technology has been licensed by BioNTech and Moderna to develop their protein replacement technologies, but it was also used for their COVID-19 vaccines. The messenger RNA-based technology developed by Karikó and the two most effective vaccines based on it, BioNTech/Pfizer and Moderna, formed the basis for the effective and successful fight against SARS-CoV-2 virus worldwide and contributed significantly to the containment of the COVID-19 pandemic. For their work, Karikó and Weissman have received numerous other awards besides the Nobel, including the Lasker–DeBakey Clinical Medical Research Award, Time Magazine's Hero of the Year 2021, and the Tang Prize Award in Biopharmaceutical Science in 2022.
Early life and education
Katalin Karikó was born in Szolnok, and grew up in Kisújszállás, Hungary, in a small home without running water, a refrigerator, or television. Her father János was a butcher, and her mother was a bookkeeper. Her father was punished for participating in the revolt of 1956. She excelled in science during her primary education, earning third place in Hungary in a biology competition. A 2024 retrospective by the University of Szeged further documents Karikó's upbringing in Kisújszállás, Hungary, where her early passion for chemistry and biology was nurtured through academic competitions, achieving top national rankings by eighth grade. This foundation is recognized as a key influence on her later breakthroughs in mRNA research. Karikó obtained a BSc degree in biology in 1978 and her PhD in biochemistry in 1982, both from the University of Szeged. She worked with Jenő Tomasz and continued her postdoctoral research at the Institute of Biochemistry, Biological Research Centre (BRC) of Hungary. From 1978 until 1985, she was listed as an intelligence asset by the Communist Hungarian secret police, something she says she was blackmailed into out of fear of repercussions on her career or reprisals against her father. She claims that she did not provide them with information nor was she active as an agent. In 1985, her lab at the BRC lost its funding, and Karikó sought work at institutions in other countries. After being offered a research position by Robert J. Suhadolnik of Temple University, Karikó left Hungary for the United States with her husband and two-year-old daughter, carrying her daughter's teddy bear stuffed with £900 that they had received from selling their car and exchanging currency on the black market.
… excerpt ends here. Continue reading the full article.






